Showing results (171-180 of 189) with videos related to

Sort By:
Pageof 19
Biomedicines|December 23, 2023
Automated Prognosis Marker Assessment in Breast Cancers Using BLEACH&STAIN Multiplexed ImmunohistochemistryTim Mandelkow, Elena Bady, Magalie C J Lurati, et al.
Plos One|July 21, 2022
High prevalence of p16 staining in malignant tumorsNoémi De Wispelaere, Sebastian Dwertmann Rico, Marcus Bauer, et al.
Archives of Pathology & Laboratory Medicine|March 14, 2024
Steroidogenic Acute Regulatory Protein Is a Useful Marker for Sex-Cord-Stroma Tumors and Normal and Neoplastic Adrenocortical TissueMaximilian Lennartz, Daniela Amezada, Doris Höflmayer, et al.
Aging|September 19, 2019
Up-regulation of lysophosphatidylcholine acyltransferase 1 (LPCAT1) is linked to poor prognosis in breast cancerPatrick Lebok, Aurelia von Hassel, Jan Meiners, et al.
The American Journal of Surgical Pathology|August 12, 2024
Prevalence of S-methyl-5'-thioadenosine Phosphorylase (MTAP) Deficiency in Human Cancer: A Tissue Microarray Study on 13,067 Tumors From 149 Different Tumor TypesNatalia Gorbokon, Niklas Wößner, Maximilian Lennartz, et al.
The American Journal of Surgical Pathology|January 25, 2024
GAD2 Is a Highly Specific Marker for Neuroendocrine Neoplasms of the PancreasMaximilian Lennartz, Nick Benjamin Dünnebier, Doris Höflmayer, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|May 17, 2024
Staining pattern of specific and cross-reacting Melan-A antibodies: A comparative study on 15,840 samples from 133 human tumor typesShiva Boroojerdi, Sören Weidemann, Anne Menz, et al.
The Journal of Pathology|April 4, 2025
A Tc1- and Th1-T-lymphocyte-rich tumor microenvironment is a hallmark of MSI colorectal cancerZhihao Huang, Tim Mandelkow, Nicolaus F Debatin, et al.
Pageof 19